The present description refers to the use of one or more strains belonging to the Lactobacillus mucosae species for the treatment and/or prevention of gastroenteritis caused by E. coli in animals including human and pharmaceutical or veterinary compositions, probiotic foods and alimentary supplements comprising the same.